Health Organizations Plan IT Investment in Patient-Centric Tech
Two-thirds of pharmaceutical companies in the Accenture survey cited improving patient outcomes as their company’s top objective for patient services.Over the next two years, most large pharmaceutical companies are planning to increase their investment in patient-centric capabilities, including remote patient monitoring and medication delivery, according to an Accenture survey of 200 pharmaceutical executives. The survey also found that 85 percent of respondents said their organizations plan to ramp-up spending on patient-centric capabilities over the next two years. The respondents are increasingly focused on patient-centric capabilities at a time when only about half (51 percent) of them rate their organization’s patient-centric capabilities as robust, and 46 percent cite little improvement in these capabilities over the last two years. "We envision patient-service technologies evolving in several ways. To be sure, there will continue to be a mass of innovation in health care IT, which impacts patient services like cognitive computing, big data, virtual reality, and wearables and sensors," Tony Romito, managing director with Accenture Life Sciences, told eWEEK. "But market leaders will be those who figure out how to best enable a truly connected experience across these technologies, from clinical trial use to compassionate use through commercial use."
Romito explained that to do this effectively, an enterprise-grade patient platform needs to be developed that can form the backbone of the patient interactions, services and technologies, and be interoperable with new innovative technologies as they continue to evolve.